Literature DB >> 20846145

Barcode technology in yeast: application to pharmacogenomics.

Daniela Delneri1.   

Abstract

The common baker's yeast, Saccharomyces cerevisiae, is one of the oldest domesticated organisms known, and has been exploited by our ancestors in several different applications, particularly in food and fermentations industries and in bioconversion and biodegradation processes. Over the years, yeast has become an excellent experimental model for biological and medical studies, thanks to its genetic tractability, well-known physiology and fast-doubling cycle. In the last decade, the advances in genome sequencing opened the doors to high-throughput studies and yeast quickly has become a model system for drug discovery and mode of action. This review provides a focused overview of the achievements in the field of human medicine and pharmacology by exploiting the molecular tools available for yeast.
© 2010 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20846145     DOI: 10.1111/j.1567-1364.2010.00676.x

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  3 in total

1.  A Simple and Rapid Protocol for Producing Yeast Extract from Saccharomyces cerevisiae Suitable for Preparing Bacterial Culture Media.

Authors:  Omid Zarei; Siavoush Dastmalchi; Maryam Hamzeh-Mivehroud
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

2.  Investigation of Bar-seq as a method to study population dynamics of Saccharomyces cerevisiae deletion library during bioreactor cultivation.

Authors:  Maren Wehrs; Mitchell G Thompson; Deepanwita Banerjee; Jan-Philip Prahl; Norma M Morella; Carolina A Barcelos; Jadie Moon; Zak Costello; Jay D Keasling; Patrick M Shih; Deepti Tanjore; Aindrila Mukhopadhyay
Journal:  Microb Cell Fact       Date:  2020-08-18       Impact factor: 5.328

3.  Fluctuating Environments Maintain Genetic Diversity through Neutral Fitness Effects and Balancing Selection.

Authors:  Farah Abdul-Rahman; Daniel Tranchina; David Gresham
Journal:  Mol Biol Evol       Date:  2021-09-27       Impact factor: 16.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.